Anacor Pharmaceuticals' IPO

Anacor Pharmaceuticals raised a round of funding on , . Investors include Public.

Anacor is a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. Anacor has focused initially o…

Articles about Anacor Pharmaceuticals' IPO: